Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for acute central serous chorioretinopathy
IRCT20180825040860N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of eplerenone in Central Serous Chorioretinopathy (CSCR), sponsored by Isfahan University of Medical Sciences. Started Sep 2019; status: completed.
02
Drugs
eplerenone
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on IRCT20180825040860N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180825040860N1.